$MRCY

Mercury Systems (MRCY) Q4 2026 Earnings Call Transcript

Mercury Systems (MRCY) reported Q4 2026 earnings with record bookings of $660M, revenue of $290M, and EBITDA margin of 16.7%. The company increased its organic growth outlook for FY 2027, citing strong demand and execution. Key drivers include increased production volumes, new development programs, and defense budget tailwinds. The company also announced a strategic agreement with Palantir to enhance operations.

Original reporting
Published Aug 25, 2026, 11:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 11:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mercury Systems (MRCY) Q4 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$MRCYBullishHigh
01

Why it matters

The earnings beat and raised guidance provide a fresh catalyst for the stock, likely prompting buying interest.

02

Market read

First disclosure of Mercury's Q4 results and FY27 outlook, offering actionable insight for traders.

03

What to watch

Potential supply‑chain constraints or slower FY27 demand could temper growth.

Relevance 8/10Novelty 9/10Timing: post‑earnings release

Background

Mercury Systems (MRCY) held its FY26 Q4 earnings call, delivering record financial metrics and an optimistic FY27 outlook.

Company-level read

Ticker impact

$MRCYBullishHigh confidence
Context

Mercury Systems reported record Q4 FY26 bookings of $660M, revenue of $290M and raised FY27 outlook, providing fresh earnings data.

Expected impact

Potential short‑term price rally as investors digest the beat and raised guidance.

Evidence & confidence

The disclosed numbers exceed prior guidance and represent material growth, a clear catalyst for buying pressure.

Market effects

Highlights strength in defense electronics and could lift peer defense contractors.

Positive for U.S. defense sector investors.

Reinforces demand trends for military-grade processing hardware worldwide.

Counterpoint

If the market has already priced in the strong backlog, the upside may be limited.

Key entities

  • Mercury Systems

    U.S. defense electronics manufacturer (ticker MRCY).

  • Palantir

    Partner in a strategic AI software agreement with Mercury.

Related articles

$MRCYHighAI 8/10

Mercury Systems (MRCY) Booked $660 Million. Why Did its Shares Fall More than 10% After Hours?

Mercury Systems (MRCY) reported record orders of $660M, up 93.1%, and a 2.28 book-to-bill ratio. Revenue rose 6.1% to $289.8M, beating estimates, but adjusted earnings missed at $0.37 per share. Shares fell over 10% after hours. The company expects fiscal 2027 revenue to approach $1.1B and adjusted EBITDA to approach $200M, but cash flow and margins remain concerns.

$MRCYMedAI 8/10

Mercury Systems Q4 revenue beats estimates as bookings surge

Mercury Systems (MRCY) reported Q4 FY26 revenue of $289.782M, beating estimates by 8.78% but missing EPS expectations. Bookings surged 93.1% YoY to $660M, driving a record backlog of over $1.9B. Management raised FY27 organic growth targets. Analysts raised price targets despite a 10.60% stock drop.

$MRCYMed

Mercury Systems, Inc. Q4 2026 Earnings Call Summary

Mercury Systems reported record Q4 2026 revenue of $660M, driven by strong demand in CPA, effectors, and space applications. Organic growth was 13% domestically, while international revenue declined 15% due to temporary delays. FY 2027 revenue is projected at $1.1B, with low double-digit growth expected. The company partnered with Palantir to enhance operations using AI. Management expects margin expansion and improved cash flow conversion over time, excluding potential upside from munitions and

$MRCYMed

Why Mercury Systems Stock Is Sinking Today

Mercury Systems (MRCY) reported Q4 2026 revenue of $289.8M, beating estimates, but shares fell 6.4% due to EPS miss ($0.37 vs. $0.38) and margin contraction (operating margin down to 5% from 8.6%). Despite record sales and backlog growth, investors are concerned about profitability and valuation.

$MRNAMed

Stocks making the biggest moves premarket: Moderna, Lowe's, Estee Lauder & more

Moderna and Merck shares surged 57% and 6% respectively after positive cancer vaccine trial results. Marvell Technology rose 11% following a $12B Google investment deal. Keysight Technologies gained 2% on better-than-expected Q3 results. Lowe's fell 2% after lowering full-year guidance. Target declined 1.5% despite revenue beats. La-Z-Boy dropped 17% on weak Q1 earnings. Mercury Systems slid 9% on lower revenue forecasts. Toll Brothers rose 1% on Q3 earnings beats. Estee Lauder gained 7% after Q

Mercury Systems (MRCY) Q4 2026 Earnings Call Transcript — alphai